Cargando…
Azithromycin reduces spontaneous and induced inflammation in ΔF508 cystic fibrosis mice
BACKGROUND: Inflammation plays a critical role in lung disease development and progression in cystic fibrosis. Azithromycin is used for the treatment of cystic fibrosis lung disease, although its mechanisms of action are poorly understood. We tested the hypothesis that azithromycin modulates lung in...
Autores principales: | Legssyer, Rachida, Huaux, François, Lebacq, Jean, Delos, Monique, Marbaix, Etienne, Lebecque, Patrick, Lison, Dominique, Scholte, Bob J, Wallemacq, Pierre, Leal, Teresinha |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1637104/ https://www.ncbi.nlm.nih.gov/pubmed/17064416 http://dx.doi.org/10.1186/1465-9921-7-134 |
Ejemplares similares
-
Dysregulated Proinflammatory and Fibrogenic Phenotype of Fibroblasts in Cystic Fibrosis
por: Huaux, François, et al.
Publicado: (2013) -
Resveratrol increases F508del-CFTR dependent salivary secretion in cystic fibrosis mice
por: Dhooghe, Barbara, et al.
Publicado: (2015) -
Impact of MIF Gene Promoter Polymorphism on F508del Cystic Fibrosis Patients
por: Melotti, Paola, et al.
Publicado: (2014) -
ΔF508 CFTR interactome remodeling promotes rescue of Cystic Fibrosis
por: Pankow, Sandra, et al.
Publicado: (2015) -
The role of pro- and anti-inflammatory responses in silica-induced lung fibrosis
por: Barbarin, Virginie, et al.
Publicado: (2005)